Cipla | CIPLA - Current Liabilities

Stock Price
1,317.80
Daily Change
-23.30 -1.74%
Monthly
0.37%
Yearly
-10.76%
Q1 Forecast
1,315.62

Cipla reported INR62.97B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Arca Biopharma USD 20.97M 8.86M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
Bio Path USD 7.86M 3.12M Jun/2025
Brainstorm Cell Therapeutics USD 9.02M 495K Sep/2025
Capricor Therapeutics USD 28.15M 249K Sep/2025
Cara Therapeutics USD 10.68M 9.48M Jun/2025
Cipla INR 62.97B 8.13B Sep/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Immunic USD 30.08M 2.77M Sep/2025
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Minerva Neurosciences USD 2.67M 143K Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
TherapeuticsMD USD 5.82M 655K Jun/2024
UPL INR 330.9B 45.21B Sep/2025